NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
Holding NRXP?
Track your performance easily

NRX Pharmaceuticals (NRXP) Stock Investors

299 Followers
Based on 757,311 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NRXP
On average, investors allocate 0.00% of their portfolios to NRXP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,311 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NRXP

1.7%
Last 7
Days
0.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NRXP, out of 757,311 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NRXP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$2.34
Based on the activity of 14,468 investors who made their portfolios public
The table shows changes in NRXP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NRXP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Lucid Group
5.93%
-0.57%
-0.23%
8.77B
Consumer Cyclical
DraftKings
5.58%
-1.48%
+0.87%
34.22B
Consumer Cyclical
Blink Charging Co
5.32%
-1.79%
-3.85%
190.16M
Industrials
Plug Power
5.11%
-1.24%
-2.96%
1.84B
Industrials
Riot Platforms
4.71%
-1.17%
-2.29%
2.16B
Financial
Bristol-Myers Squibb
3.44%
-1.33%
-2.60%
100.34B
Healthcare
Block
4.21%
-1.17%
-2.73%
41.45B
Technology
Nio
9.91%
-1.13%
-1.17%
11.30B
Consumer Cyclical
XPeng, Inc. ADR
5.47%
-1.34%
-2.89%
8.61B
Consumer Cyclical
Marathon Digital Holdings
5.33%
-0.71%
-1.46%
4.67B
Financial
Based on the activity of 757,311 active portfolios
Open your Smart Portfolio

NRXP Investor Analysis

NRXP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.9%
of NRXP holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
NRXP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
68.3%
of NRXP holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
NRXP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
26.8%
of NRXP holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of NRXP stock investors
See who invests in NRXP according to age group and performance.

FAQ

How many retail Investors hold NRXP?
<0.1% of TipRanks' retail investors hold NRXP in their portfolios.
    What is NRXP Investor Sentiment?
    NRXP’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of NRXP in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of NRXP in the last 7 days.
        What percentage of retail investors changed their holding of NRXP in the last 30 days?
        ▲ 0.1% of TipRanks' retail investors changed their holding of NRXP in the last 30 days.
          What is the average age of retail investors who hold NRXP?
          The average age of NRXP Holders is between 35–55.
            What other stocks have NRXP investors also bought?
            NRXP Investors also bought LCID, DKNG, BLNK, PLUG, RIOT, BMY, SQ, NIO, XPEV, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              EXELExelixis
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis